Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy

被引：1
|
作者：
Cornell, Robert Frank [1 ]
Goldhaber, Samuel Z. [2 ]
Engelhardt, Brian G. [1 ]
Moslehi, Javid [3 ]
Jagasia, Madan [1 ]
Patton, Daryl [4 ]
Harrell, Shelton Lacy [1 ]
Hall, Robert L. [1 ]
Wyatt, Houston [1 ]
Piazza, Gregory [2 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
[2] Harvard Med Sch, Div Cardiovasc Med, Brigham & Womens Hosp, Boston, MA USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA
[4] Vanderbilt Inst Clin & Translat Res, Nashville, TN USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112577
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1233
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
    Cornell, Robert Frank
    Goldhaber, Samuel Z.
    Engelhardt, Brian G.
    Moslehi, Javid
    Jagasia, Madan
    Patton, Daryl
    Harrell, Shelton
    Hall, Robert
    Wyatt, Houston
    Piazza, Greg
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [2] Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
    Cornell, Robert F.
    Goldhaber, Samuel Z.
    Engelhardt, Brian G.
    Moslehi, Javid
    Jagasia, Madan
    Harrell, Shelton
    Rubinstein, Samuel M.
    Hall, Robert
    Wyatt, Houston
    Piazza, Gregory
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (04) : 555 - 561
  • [3] Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy: Real-World Examination of the Impede Study
    Hwang, Grace
    Szabatura, Audrea
    Leblebjian, Houry
    Aktas-Samur, Anil
    Laubach, Jacob P.
    Parnes, Aric D.
    BLOOD, 2020, 136
  • [4] Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy
    Covut, Fahrettin
    Sanfilippo, Kristen M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2022, (01) : 363 - 367
  • [5] Incidence and Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Agents
    Kimpton, Miriam
    Buyting, Ryan
    Corsi, Daniel J.
    Rupani, Natasha
    Carrier, Marc
    McCurdy, Arleigh
    BLOOD, 2016, 128 (22)
  • [6] Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study
    Pegourie, Brigitte
    Karlin, Lionel
    Benboubker, Lotfi
    Orsini-Piocelle, Frederique
    Tiab, Mourad
    Auger-Quittet, Sophie
    Rodon, Philippe
    Royer, Bruno
    Leleu, Xavier
    Bareau, Benoit
    Cliquennois, Manuel
    Fuzibet, Jean-Gabriel
    Voog, Eric
    Belhadj-Merzoug, Karim
    Decaux, Olivier
    Rey, Philippe
    Slama, Bohrane
    Leyronnas, Cecile
    Zarnitsky, Charles
    Boyle, Eileen
    Bosson, Jean Luc
    Pernod, Gilles
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (06) : 635 - 640
  • [7] Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy
    Musallam, Khaled M.
    Dahdaleh, Fadi S.
    Shamseddine, Ali .
    Taher, Ali T.
    THROMBOSIS RESEARCH, 2009, 123 (05) : 679 - 686
  • [8] Comparing venous thromboembolism prophylactic strategies for ambulatory multiple myeloma patients on immunomodulatory drug therapy
    Dede, Ruth J.
    Pruemer, Jane M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 248 - 255
  • [9] External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs
    Dima, Danai
    Li, Ang
    Granat, Lauren M.
    Dhillon, Puneet
    Chamseddine, Fatima
    Yalamanchali, Anirudh
    Mirzai, Saeid
    Wei, Wei
    Samaras, Christy J.
    Valent, Jason
    Anwer, Faiz
    Khouri, Jack
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (02) : 280 - 284
  • [10] External Validation of the Saved Score for Venous Thromboembolism Risk Stratification in Patients with Multiple Myeloma Receiving Immunomodulatory Drugs
    Dima, Danai
    Li, Ang
    Granat, Lauren M.
    Dhillon, Puneet
    Gurnari, Carmelo
    Yalamanchali, Anirudh
    Mirzai, Saeid
    Wei, Wei
    Faiman, Beth M.
    Williams, Louis S.
    Mazzoni, Sandra
    Samaras, Christy J.
    Anwer, Faiz
    Valent, Jason
    Khouri, Jack
    BLOOD, 2022, 140 : 11299 - 11300
12345